Skip to main content
Premium Trial:

Request an Annual Quote

Lonza, Bar Harbor Biotech Expand Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bar Harbor BioTechnology and Lonza have expanded their distribution partnership to include new qPCR array tools, Lonza said today.

The companies first struck an exclusive distribution agreement in 2008 that covered the StellARray Gene Expression System, which is used by researchers to accurately detect small changes in gene expression or to measure copy number variations. Lonza will now distribute the system along with the Global Pattern Recognition 2.0 software, Custom Plate Designer, and XenoQ products, which were launched in January.

Lonza's Research Solutions Director of Product Marketing Dietmar Pein said that expression profiling by qPCR arrays, particularly when used in combination with new solutions that address normalization and customization challenges, will become more important in life sciences research.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.